AmerisourceBergen elevates Steve Collis to president and COO
The Big Three distributor’s board of directors has appointed Collis, currently president of AmerisourceBergen Drug Corp. (ABDC, the pharma wholesaling arm of the company) to president and chief operating officer of the parent. He will report to R. David Yost, AmerisourceBergen’s CEO, who previously also held the title of president.
Collis is now responsible for all AmerisourceBergen business units, including ABDC, AmerisourceBergen Specialty Group (ABSG), AmerisourceBergen Packaging Group (ABPG) and AmerisourceBergen Consulting Services (ABCS). ABSG and ABCS previously reported to Yost, and ABPG previously reported to Michael DiCandilo, EVP and CFO.
Collis, who has been at AmerisourceBergen for 16 years, has been president of ABSG since 1999; that unit is now a fast-growing, $16-billion part of the company. This month, the company also announced its FY2010 results, with revenue reaching a new record, $78.0 billion, up 8.6%, and gross profit of $2.4 billion, up 12.2%.
Elevate Your Commercial Operations with Close-up CRM
September 6th 2024Discover a powerful, cost-effective, and robust CRM platform that maximizes your budget. Seamlessly integrate data from any source, streamline marketing efforts, and optimize HCP promotion, key account management, and digital marketing campaigns. Reduce CRM costs and reallocate funds to enhance data analytics, market research, and human capital, boosting overall commercial operations impact.
AI-Enabled Pharma CRM Driving Intelligent Customer Engagement
September 6th 2024Discover our unparalleled CRM solution that integrates AI/ML for enhanced stability, security, and performance. Leverage our team of 1000+ experts and 25K+ data provider partners. Our cloud-based SaaS model allows rapid global deployment and scalability, while our clean UX focuses on intuitive AI experience and rapid user adoption. Ensure swift 80% physician onboarding with our intuitive AI platform, speeding strategic integration.
